Corus Pharma
Corus Pharma Inc, a Seatle-based biotech and specialty drug company focused on respiratory and infectious diseases.
Employees
Enterprise value
$416m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | $416m Valuation: $416m | Acquisition | |
| Total Funding | 000k | ||
RBC Capital Markets(exited)
Novo Holdings(exited)
Integra Ventures(exited)
Anthem Venture Partners(exited)
OrbiMed(exited)
Carnegie(exited)
MPM BioImpact(exited)
Burrill(exited)
Cascade Investment(exited)
SunAmerica Ventures(exited)
MDS Capital(exited)
Pacific Rim Ventures(exited)
Cystic Fibrosis Foundation(exited)
Lumira Ventures(exited)
Novo Seeds(exited)
Gilead Sciences(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads